ASLAN Pharmaceuticals
About:
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Website: http://aslanpharma.com
Twitter/X: AslanPharma
Top Investors: K2 HealthVentures, Surveyor Capital, Vivo Capital, Armentum Partners, Daiwa Corporate Investment
Description:
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in clinical-stage immunology and oncology-focused biopharmaceuticals.
Total Funding Amount:
$186M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Singapore, Central Region, Singapore
Founded Date:
2010-01-01
Contact Email:
contact(AT)aslanpharma.com
Founders:
Carl Firth
Number of Employees:
11-50
Last Funding Date:
2024-03-13
IPO Status:
Public
Industries:
© 2025 bioDAO.ai